IL164814A0 - Preparations for topical administration of substances having antiandrogenic activity - Google Patents

Preparations for topical administration of substances having antiandrogenic activity

Info

Publication number
IL164814A0
IL164814A0 IL16481404A IL16481404A IL164814A0 IL 164814 A0 IL164814 A0 IL 164814A0 IL 16481404 A IL16481404 A IL 16481404A IL 16481404 A IL16481404 A IL 16481404A IL 164814 A0 IL164814 A0 IL 164814A0
Authority
IL
Israel
Prior art keywords
preparations
substances
topical administration
antiandrogenic activity
antiandrogenic
Prior art date
Application number
IL16481404A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of IL164814A0 publication Critical patent/IL164814A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL16481404A 2002-04-27 2004-10-25 Preparations for topical administration of substances having antiandrogenic activity IL164814A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10218963A DE10218963A1 (de) 2002-04-27 2002-04-27 Zubereitungen zur topischen Applikation von antiandrogen wirksamen Substanzen
PCT/EP2003/003837 WO2003093243A1 (de) 2002-04-27 2003-04-14 Zubereitungen zur topischen applikation von antiandrogen wirksamen substanzen

Publications (1)

Publication Number Publication Date
IL164814A0 true IL164814A0 (en) 2005-12-18

Family

ID=29264882

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16481404A IL164814A0 (en) 2002-04-27 2004-10-25 Preparations for topical administration of substances having antiandrogenic activity

Country Status (17)

Country Link
EP (1) EP1501806B1 (xx)
JP (1) JP4633459B2 (xx)
AR (1) AR039662A1 (xx)
AT (1) ATE321756T1 (xx)
AU (1) AU2003229658B2 (xx)
BR (1) BRPI0309579B8 (xx)
CA (1) CA2483786C (xx)
DE (2) DE10218963A1 (xx)
DK (1) DK1501806T3 (xx)
ES (1) ES2256735T3 (xx)
IL (1) IL164814A0 (xx)
MX (1) MXPA04009571A (xx)
MY (1) MY129714A (xx)
PE (1) PE20031044A1 (xx)
PT (1) PT1501806E (xx)
TW (1) TWI285637B (xx)
WO (1) WO2003093243A1 (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1634874A4 (en) 2003-06-12 2008-04-02 Chugai Pharmaceutical Co Ltd imidazolidine
WO2005060661A2 (en) 2003-12-19 2005-07-07 The Regents Of The University Of California Methods and materials for assessing prostate cancer therapies
CA2554696C (en) * 2004-02-13 2009-06-30 Warner-Lambert Company Llc Androgen receptor modulators
CN100475781C (zh) * 2004-02-13 2009-04-08 沃尼尔·朗伯有限责任公司 雄激素受体调节剂
US7718684B2 (en) 2004-02-24 2010-05-18 The Regents Of The University Of California Methods and materials for assessing prostate cancer therapies and compounds
WO2005100305A1 (en) 2004-04-13 2005-10-27 Warner-Lambert Company Llc Androgen modulators
CA2562672C (en) 2004-04-22 2009-09-29 Warner-Lambert Company Llc 4-cyano-phenoxy derivatives as androgen modulators
WO2006006065A1 (en) * 2004-07-08 2006-01-19 Warner-Lambert Company Llc Androgen modulators
BRPI0514706A (pt) * 2004-08-31 2008-06-24 Warner Lambert Co moduladores de androgênio
TW200724139A (en) 2005-05-05 2007-07-01 Warner Lambert Co Androgen modulators
US7709517B2 (en) 2005-05-13 2010-05-04 The Regents Of The University Of California Diarylhydantoin compounds
PT3412290T (pt) 2006-03-27 2021-04-19 Univ California Modulador do recetor de androgénios para o tratamento de cancro da próstata e doenças associadas ao recetor de androgénios
JP5350217B2 (ja) 2006-03-29 2013-11-27 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア ジアリールチオヒダントイン化合物
CA2966280A1 (en) 2007-10-26 2009-04-30 The Regents Of The University Of California Diarylhydantoin compounds
EA028869B1 (ru) 2010-02-16 2018-01-31 Арагон Фармасьютикалс, Инк. Модуляторы рецептора андрогенов и их применение
RU2503446C2 (ru) * 2012-02-07 2014-01-10 Алексей Валентинович Одинцов Средство для роста волос (варианты) и способ лечения облысения
NZ745682A (en) 2012-09-26 2019-09-27 Aragon Pharmaceuticals Inc Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
PL222631B1 (pl) * 2012-11-14 2016-08-31 Gdański Univ Medyczny Kompozycja farmaceutyczna zawierająca roksytromycynę, sposób jej wytwarzania oraz zastosowanie medyczne tej kompozycji i produkt leczniczy zawierający kompozycję
WO2014078929A1 (pt) * 2012-11-26 2014-05-30 Universidade Federal De Minas Gerais - Ufmg Formulações tópicas para a prevenção e tratamento da alopecia e para inibição do crescimento de pêlos
JOP20200097A1 (ar) 2013-01-15 2017-06-16 Aragon Pharmaceuticals Inc معدل مستقبل أندروجين واستخداماته
CN103965112A (zh) * 2014-05-13 2014-08-06 上海孚一生物科技有限公司 一种具有抗雄激素活性的化合物、制备方法及其应用
TWI726969B (zh) 2016-01-11 2021-05-11 比利時商健生藥品公司 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
CN111479560A (zh) 2017-10-16 2020-07-31 阿拉贡药品公司 用于治疗非转移性去势难治性前列腺癌的抗雄激素

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2693461B1 (fr) * 1992-07-08 1994-09-02 Roussel Uclaf Nouvelles phénylimidazolidines substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
US5411981A (en) * 1991-01-09 1995-05-02 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
FR2716110B1 (fr) * 1994-02-16 1996-04-05 Roussel Uclaf Compositions cosmétiques ou pharmaceutiques comprenant des liposomes.
AU726572B2 (en) * 1994-02-16 2000-11-09 Aventis Pharma S.A. Cosmetics or pharmaceutical compositions consisting of liposomes

Also Published As

Publication number Publication date
WO2003093243A1 (de) 2003-11-13
BR0309579B1 (pt) 2014-10-07
MY129714A (en) 2007-04-30
BRPI0309579B8 (pt) 2021-05-25
EP1501806B1 (de) 2006-03-29
PT1501806E (pt) 2006-06-30
DE50302818D1 (de) 2006-05-18
ES2256735T3 (es) 2006-07-16
JP2005535584A (ja) 2005-11-24
CA2483786A1 (en) 2003-11-13
AU2003229658A1 (en) 2003-11-17
PE20031044A1 (es) 2004-02-09
AR039662A1 (es) 2005-03-02
MXPA04009571A (es) 2005-01-11
CA2483786C (en) 2011-08-09
TW200407312A (en) 2004-05-16
JP4633459B2 (ja) 2011-02-16
ATE321756T1 (de) 2006-04-15
EP1501806A1 (de) 2005-02-02
DK1501806T3 (da) 2006-05-29
DE10218963A1 (de) 2003-11-20
TWI285637B (en) 2007-08-21
BR0309579A (pt) 2005-03-01
AU2003229658B2 (en) 2010-07-29

Similar Documents

Publication Publication Date Title
IL164814A0 (en) Preparations for topical administration of substances having antiandrogenic activity
AU2003257666A1 (en) COMPOUND HAVING TGFss INHIBITORY ACTIVITY AND MEDICINAL COMPOSITION CONTAINING THE SAME
AU2003264427A1 (en) Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same
HUP0401923A3 (en) New urea derivatives having pharmacological activity and pharmaceutical compositions containing them
HU0103988D0 (en) New compounds with pharmaceutical activity
HU0004123D0 (en) New compounds with pharmaceutical activity
HU0103987D0 (en) New compounds with pharmaceutical activity
HK1068812A1 (en) Drug preparations
AU2003246810A1 (en) Diphenylpyridine derivatives, the preparation thereof, and pharmaceutical compositions containing said derivatives
AU2003265225A1 (en) Preparations for topical skin use and treatment
AU2003223005A1 (en) Application device for topical administration of pharmaceutical agents
EP1465656A4 (en) PHARMACEUTICAL COMPOSITIONS AND METHODS FOR MODULATING T-CELL ACTIVITY THROUGH GONADOTROPHIN HORMONE I AND II (GNRH-I AND GNRH-II), ADHESION, MIGRATION AND EXTRAVASATION THEREOF
AU2003222786A1 (en) Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions
IL166621A0 (en) Polymorph of n-methyl-n-(3-ä-3-Ä2-thienylcarbonylÜ-pyrazol-Ä1,5-alphaÜpyrimidin-7-ylüacetamide and pharmaceutical compositions containing the same
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
AU2003276572A1 (en) Pharmaceutical dosage forms of biguanide-sulfonylurea combinations
IL146449A0 (en) Method and pharmaceutical preparations for reducing the activity of cells
AU2002366799A1 (en) Allantoin-containing preparations for administration as gels and aerosols
EP1475095A4 (en) PERCUTANEOUS PREPARATIONS
HUP9802716A3 (en) Pharmaceutical composition of analgesic activity
AU2001248943A1 (en) Pharmaceutical curative compound
AU2002328000A1 (en) Use of substances with oxytocin activity for the preparation of a pharmaceutical composition against inflammation
AU2003201853A1 (en) Skin preparations for external use
GB9902227D0 (en) Pharmaceutical composition for topical administration
AU8028600A (en) Methods, pharmaceutical and therapeutic compositions for administering adenosine

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed